ICP
Interchange Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
6,720
-699
| -9% | -$34K | 0.08% | 205 |
|
|
2025
Q1 | $252K | Sell |
7,419
-1,121
| -13% | -$38.1K | 0.07% | 225 |
|
|
2024
Q4 | $313K | Buy |
8,540
+331
| +4% | +$12.1K | 0.11% | 178 |
|
|
2024
Q3 | $386K | Sell |
8,209
-532
| -6% | -$25K | 0.14% | 166 |
|
|
2024
Q2 | $472K | Buy |
8,741
+1,616
| +23% | +$87.3K | 0.17% | 143 |
|
|
2024
Q1 | $489K | Buy |
7,125
+505
| +8% | +$34.6K | 0.33% | 72 |
|
|
2023
Q4 | $413K | Buy |
6,620
+855
| +15% | +$53.4K | 0.31% | 76 |
|
|
2023
Q3 | $262K | Buy |
5,765
+330
| +6% | +$15K | 0.21% | 120 |
|
|
2023
Q2 | $323K | Buy |
5,435
+607
| +13% | +$36.1K | 0.25% | 99 |
|
|
2023
Q1 | $218K | Buy |
+4,828
| New | +$218K | 0.12% | 186 |
|
|
2022
Q4 | – | Sell |
-5,714
| Closed | -$373K | – | 132 |
|
|
2022
Q3 | $373K | Sell |
5,714
-1,748
| -23% | -$114K | 0.41% | 67 |
|
|
2022
Q2 | $453K | Buy |
7,462
+121
| +2% | +$7.35K | 0.51% | 57 |
|
|
2022
Q1 | $460K | Buy |
7,341
+1,059
| +17% | +$66.4K | 0.47% | 67 |
|
|
2021
Q4 | $476K | Buy |
+6,282
| New | +$476K | 0.48% | 70 |
|
|
2021
Q2 | – | Sell |
-7,568
| Closed | -$1.01M | – | 123 |
|
|
2021
Q1 | $1.01M | Sell |
7,568
-2,185
| -22% | -$292K | 0.55% | 53 |
|
|
2020
Q4 | $1.49M | Buy |
+9,753
| New | +$1.49M | 0.81% | 22 |
|